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Abstract
The genome and antigens of human cytomegalovirus
(HCMV) are frequently found in prostatic carcinoma.
However, whether this infection is causative or is an
epiphenomenon is not clear. We therefore investigated
the ability of HCMV to promote metastatic processes,
defined by tumor cell adhesion to the endothelium and
extracellular matrix proteins. Experiments were based
on the human prostate tumor cell line PC3, either
infected with the HCMV strain Hi (HCMVHi) or trans-
fected with cDNA encoding the HCMV-specific imme-
diate early protein IEA1 (UL123) or IEA2 (UL122).
HCMVHi upregulated PC3 adhesion to the endothelium
and to the extracellular matrix proteins collagen,
laminin, and fibronectin. The process was accom-
panied by enhancement of B1-integrin surface expres-
sion, elevated levels of integrin-linked kinase, and
phosphorylation of focal adhesion kinase. IEA1 or
IEA2 did not modulate PC3 adhesion or B1-integrin ex-
pression. Based on this in vitro model, we postulate a
direct association between HCMV infection and pros-
tate tumor transmigration, which is not dependent on
IEA proteins. Integrin overexpression, combined with
themodulation of integrin-dependent signalling, seems
to be, at least in part, responsible for a more invasive
PC3Hi tumor cell phenotype. Elevated levels of c-myc
found in IEA1-transfected or IEA2-transfected PC3 cell
populations might promote further carcinogenic pro-
cesses through accelerated cell proliferation.
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Introduction
Human cytomegalovirus (HCMV) is a ubiquitous herpes
virus characterized by lifelong persistent infection. The fre-
quency of infection ranges from 50% to 90% in the adult
population and varies with socioeconomic status and, to
some extent, geographic location. HCMV causes severe
complications in immunocompromised individuals. HCMV
is also a leading cause of virus-associated birth defects, is
associated with atherosclerosis and coronary restenosis,
and has been suggested as a cofactor in the progression of
HIV-1 infection.
Based on serological andmolecular studies, it has also been
assumed that HCMV might be involved in the development
and etiology of human malignancies, including colon carci-
noma, Kaposi’s sarcoma, cervical carcinoma, prostate adeno-
carcinoma, and pediatric malignancies such as Wilm’s tumor
and neuroblastoma [1]. The detection of viral DNA, mRNA, and/
or antigens in tumor tissues led to the hypothesis that HCMV
catalyzes oncogenic processes (oncomodulation), which might
result in a more malignant phenotype.
However, this hypothesis is controversial because HCMV is
not restricted to tumorous organs but also infects organs in a high
number of healthy individuals. Reports have also documented
that viral DNA is often not retained in transformed cells and tumor
samples [1]. Therefore, it is still uncertain whether HCMV con-
tributes to oncomodulation and malignancy progression.
From a clinical viewpoint, the evaluation of HCMV’s role
in tumor pathology is highly desirable. Patients with HCMV+
tumors might benefit from a combination of antiviral and anti-
tumor therapy, if a link between HCMV infection and carcino-
genesis can be proved. This is particularly true for patients
suffering from prostate carcinoma—the most common cancer
in men in the United States and in the western world, with
increasing incidence and mortality rates [2,3]. Epidemiological
studies indicate a significant association between prostate
cancer incidence and increased exposure to sexually trans-
mitted diseases, implying that a sexually transmissible agent(s)
might increase the risk of prostate cancer [4,5]. Recent data
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from Samanta et al. demonstrate that persistent infection by
HCMV, which can be sexually transmitted, occurs in a high
percentage of neoplastic prostatic epithelial lesions. Based
on the specific detection of HCMV nucleic acids and proteins
in biopsy specimens of prostate carcinoma patients,
Samanta et al. [6] postulated a direct contribution of HCMV
to the history of prostatic cancer. Nevertheless, the specific
localization of virus material within a tumor is not a definitive
evidence of a causal link between HCMV infection and
human cancer.
In fact, the significance of HCMV in the pathogenesis
of prostate cancer has remained obscure. Contrary to the
abovementioned findings, polymerase chain reaction in
prostatic tissue samples obtained during radical prosta-
tectomy did not detect the genome sequences of HCMV in
any sample, thus failing to support a viral etiology of pros-
tate cancer [7].
To determine whether HCMV plays a role in prostate
cancer or whether the virus is only a passenger in tumor
cells, we examined the influence of HCMV on the adhesive
capacity of tumor cells in a well-established cell culturemodel
[8]. Experiments were based on the human prostate tumor
cell line PC3, which was either infected with the HCMV
strain Hi (HCMVHi) or transfected with cDNA encoding the
HCMV-specific immediate early protein IEA1 (UL123) or
IEA2 (UL122). Our data present strong evidence that HCMV
upregulates prostate tumor cell adhesion to the endothelium
and to the extracellular matrix proteins collagen, laminin, and
fibronectin. HCMVHi infection leads to enhancement of
b1-integrin surface expression, elevated levels of integrin-
linked kinase (ILK), and phosphorylation of focal adhesion
kinase (FAK), as well as altered c-myc expression. This is
the first report to reveal a direct link between HCMV infection
and prostate carcinoma invasion.
Materials and Methods
Cell Cultures
Human umbilical vein endothelial cells (HUVEC) were
isolated from human umbilical veins and harvested by enzy-
matic treatment with chymotrypsin. HUVEC were grown in
Medium 199 (M199; Biozol, Munich, Germany) supple-
mented with 10% fetal calf serum (FCS), 10% pooled human
serum, 20 mg/ml endothelial cell growth factor (Boehringer
Mannheim, Mannheim, Germany), 0.1% heparin, 100 ng/ml
gentamicin, and 20 mM HEPES buffer (pH 7.4). Subcultures
from passages 2 to 6 were selected for experimental use.
The human prostate tumor cell lines PC3, DU-145, and
LNCaP were obtained from DSMZ (Braunschweig, Ger-
many). Tumor cells were grown and subcultured in RPMI
1640 (Gibco/Invitrogen, Karlsruhe, Germany). The medium
contained 10% FCS, 2% HEPES buffer (1 M, pH 7.4), 2%
glutamine, and 1% penicillin/streptomycin. Subcultures from
passages 7 to 11 were selected for experimental use. Cell
viability was determined by trypan blue (Gibco/Invitrogen).
All cells were maintained in an incubator at 37jC, with a
5% CO2 humidified atmosphere.
HCMV Infection
HCMVHi was isolated from the bronchial lavage of an HIV
patient. HCMVHi was cultured in human foreskin fibroblasts
(HFF) and incubated in MEM (Biochrom, Berlin, Germany)
supplemented with 2% FCS, 20 mM HEPES buffer, 2%
bicarbonate, and 1% penicillin/streptomycin. Virus titer was
determined by plaque titration in HFF, as described pre-
viously [9]. PC3 cells were infected at amultiplicity of infection
(MOI) of 0.1 or 1 in RPMI 1640 supplemented with 2% FCS
(PC3Hi). After 24 hours at 37jC, the medium was removed
and replaced by RPMI 1640 supplemented with 10% FCS
for 1 or 3 days. Immunoperoxidase staining against the
HCMV-specific immediate early protein (72-kDa immediate
early Ag, IEA, UL123; Biotrend, Ko¨ln, Germany) or the
nuclear late protein (67-kDa late Ag, LA; DuPont, Bad Hom-
burg, Germany) was carried out routinely after each sub-
culture [10]. For control purposes, an irrelevant antibody
directed against HSV glycoprotein Bwas used. The efficiency
of HCMVHi infection was always about 30% related to IEA-
expressing cells. Mock-infected inocula were prepared in an
identical fashion, except that cell monolayers were not
infected with HCMVHi. Virus inactivation was carried out by
the exposure of virus solution to UV light (220 V, 12 W) for
15 minutes [11]. Samples of irradiated virus were then used
to infect PC3. UV-irradiated samples were free of infectious
virus, as detected by plaque titration.
Transfection Procedure
PC3 cells were transfected using the Effectene Trans-
fection assay (Qiagen, Hilden, Germany). cDNA encoding
HCMV IEA1 (UL123) was cloned into the pBS+/ vector
(Stratagene, Heidelberg, Germany) and inserted in the
expression vector pHM135. cDNA encoding HCMV IEA2
(UL122) was cloned into the pBS+/ vector (Stratagene)
and inserted in the expression vector pHM134. cDNA encod-
ing HCMV IEA1 and IEA2 was cloned into the pUC18 vector
(Fermentas, St. Leon-Rot, Germany) and inserted in the
expression vector pHM127 (expression vectors were a kind
gift from T. Stamminger, University of Erlangen-Nu¨rnberg,
Erlangen, Germany). Control cells were transfected with the
vectors alone. Subconfluent PC3 cells were transfected with
8 g of DNA for 6 hours at 37jC in 75-cm2 culture flasks. Sub-
sequently, cells were washed with phosphate-buffered saline
(PBS) without Ca2+ and Mg2+ and were incubated overnight
in a complete medium. The efficiency of transfection was
investigated by immunoperoxidase staining against the
HCMV-specific immediate early protein. The average rate
of transfected PC3 cells was around 45% (PC3pHM135,
PC3pHM134, and PC3pHM127). The viability of the cells, which
was controlled by trypan blue dye exclusion, was > 90%.
Tumor Cell Adhesion to HUVEC
HUVEC were transferred to six-well multiplates (Falcon
Primaria; BDBiosciences, Heidelberg,Germany) in complete
HUVEC medium. When confluency was reached, PC3 cells
were detached from culture flasks by accutase treatment
(PAA Laboratories, Co¨lbe, Germany), and 0.5  106 cells
were then added to the HUVEC monolayer for 60 minutes.
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Subsequently, nonadherent tumor cells were washed off
using warmed (37jC) Medium 199. The remaining cells were
fixed with 1% glutaraldehyde. In each experimental setting
(PC3 vs PC3Hi), adherent tumor cells were counted in five
different fields of a defined size (5  0.25 mm2) using a
phase-contrast microscope, and the mean cellular adhesion
rate was calculated.
Attachment of Tumor Cells to Extracellular
Matrix Components
Twenty-four-well plates were coated overnight with colla-
gen (diluted to 100 mg/ml in PBS; Seromed Biochrom, Berlin,
Germany), laminin (diluted to 50 mg/ml in PBS; BD Bio-
sciences), or fibronectin (diluted to 50 mg/ml in PBS; BD Bio-
sciences). Plastic dishes served as background control.
Plates were washed with 1% bovine serum albumin (BSA)
in PBS to block nonspecific cell adhesion. Thereafter, 1105
tumor cells/well were added for 60 minutes. Subsequently,
nonadherent tumor cells were washed off, and the remaining
adherent cells were fixed with 1% glutaraldehyde and
counted microscopically. The mean cellular adhesion rate
(adherent cellscoated well  adherent cellsbackground) was cal-
culated from five different observation fields.
FACScan Analysis
The oncoprotein expression, as well as the integrin ex-
pression, of PC3 vs PC3Hi tumor cells was investigated by
flow cytometry. To determine if protein/integrin modulation
was restricted to HCMV-infected PC3 cells, cell cultures were
double-stained using monoclonal antibodies directed against
the HCMV-specific 72-kDa IEA and against the protein in
question. Tumor cells were harvested by accutase treatment
and washed in blocking solution (PBS and 0.5% BSA). To
carry out integrin surface analysis, cells were fixed with
100 ml of fixation medium (Fix&Perm; Biozol-An der Grub
Bioresearch, Eching,Germany) andwashed twice in blocking
solution (PBS and 0.5% BSA). Subsequently, they were
incubated for 60 minutes at 4jC with 100 ml of permeabiliza-
tion medium (Fix&Perm) together with the monoclonal anti-
body anti–72-kDa IEA (1:50, mouse IgG1-K; Biotrend). This
process was repeated to allow labeling with the fluorescein
isothiocyanate (FITC)–conjugated anti– IgK monoclonal an-
tibody (1:20, rat–antimouse IgK; Becton Dickinson, Heidel-
berg, Germany). In a further step, tumor cells were marked
with the PE-conjugated monoclonal antibodies anti-CD49a
(a1b1), anti-CD49b (a2b1), anti-CD49c (a3b1), anti-CD49d
(a4b1), anti-CD49e (a5b1), or anti-CD49f (a6b1; all from Bec-
tonDickinson). Dot-plot quadrant analyses have been carried
out to display the percentage distribution of PC3-expressing
FITC–IEA and/or PE–integrin (IEA+/integrin+, IEA+/integ-
rin, IEA/integrin+, and IEA/integrin). IEA and IEA+ cells
were gated to obtain two distinct cell populations: population I
(IEA+) as HCMV-infected cells, and population II (IEA) as
noninfected tumor cells. Integrin expression of both PC3 sub-
types was then detected by FACScan analysis [FL-2H(log)
channel histogram analysis; 1  104 cells/scan]. To eval-
uate the background staining of FITC-labeled IEA, FITC-
conjugated anti-IgK (1:20, rat–antimouse) was used. Mouse
IgG1–PE was used as an isotype control for integrin mouse
IgG1–FITC–conjugated antibodies.
To analyze c-myc oncoproteins, cells were fixedwith 5ml of
cold (20jC) methanol/acetone (1:1, vol/vol) for 15 minutes.
They were then incubated with the monoclonal antibody anti–
72-kDa IEA and labeled with FITC, as described. Subse-
quently, monoclonal antibodies against c-myc (1:100, clone
9E10, mouse IgG1; Becton Dickinson) were added for
60 minutes, followed by an additional incubation with goat–
antimouse IgG–PE (1:50; Becton Dickinson) for a further 30
to 60 minutes. PE-labeled IgG1 (1:50, goat–antimouse;
Becton Dickinson) was used as the respective isotype control.
Western Blot Analysis
Total oncoprotein/integrin content in PC3 vs PC3Hi cells
was evaluated by Western blot analysis. Cells were lysed in
lysis buffer containing 96.4%Triton X-100, 1%orthovanadate
(2 mM), 1% okadic acid (10 mM), 1.2% PIM (12 ml/ml), and
0.4% PMSF (4 ml/ml). Proteins (50 mg) were separated by
sodium dodecyl sulfate–polyacrylamide gel electrophoresis
on 10% gels for 60 minutes at 100 V, and then transferred
to nitrocellulose membranes. After blocking, the mem-
branes were incubated overnight with antibodies against
CD49b (1:250, mouse IgG2a), CD49c (1:1000, rabbit),
CD49d (1:200, mouse IgG), c-myc (1:250, mouse IgG1), ILK
(clone 3), FAK (clone 77), and phospho-specific FAK (pY397,
clone 18; all from Becton Dickinson). HRP-conjugated goat–
antimouse or goat–antirabbit IgG (1:5000; Upstate Biotech-
nology, Lake Placid, NY) served as secondary antibodies. The
membrane was briefly incubated with ECL detection reagent
(Amersham-GE Healthcare, Braunschweig, Germany) to vi-
sualize the proteins and was exposed to an X-ray film (Hyper-
film EC; Amersham). b-Actin (1:1000, mouse; Sigma,
Taufkirchen, Germany) served as internal control.
Reverse Transcriptase–Polymerase Chain Reaction
(RT-PCR)
CD49d (a4b1) mRNA was evaluated by RT-PCR. Tumor
cells were seeded in 50-ml culture flasks (Falcon Primaria;
25-cm2 growth area). Total RNA was isolated and extracted
using QIAshredder (250) and RNeasy kit (Qiagen) according
to the manufacturer’s instruction. RNA samples were then
treated with 80 U/ml RNase-free DNase I (Boehringer Mann-
heim) for 60 minutes at 37jC to eliminate amplifiable con-
taminating genomic DNA. Subsequently, samples were
incubated for 10 minutes at 65jC to inactivate DNase.
Complementary DNA was synthesized from 1 mg of total
RNA per sample with a 60-minute incubation at 42jC, using
theMoloneymurine leukemia virusRT (Invitrogen, Karlsruhe,
Germany) and oligo(dT) priming (Boehringer Mannheim).
Amplification was carried out by gene-specific primers and
Platinum-Taq polymerase (Invitrogen) in a Mastercycler Gra-
dient thermocycler (Eppendorf, Hamburg, Germany). For
DNA elimination, samples were treated with RNase-free DN-
ase (Qiagen). cDNA synthesis (RT-PCR) was performed
according to PowerScript protocol (Becton Dickinson).
CD49d primer sequences were 5V-TGG CGT GGTACA ACT
TGA CTG-3V and 5V-CAT GCG CAA CAT TCT CAT CCT-3V.
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Internal controls for PCR were performed by running par-
allel reaction mixtures with the housekeeping gene GAPDH
(5V-ATC TTC CAG GAG CGA GAT CC-3V and 5V-ACC ACT
GAC ACG TTG GCA GT-3V). Reactions were performed in
the presence of 0.5 ml of cDNA, with an initial incubation step
at 95jC for 2 minutes. Cycling conditions consisted of dena-
turation at 95jC for 30 seconds, annealing at 30jC (GAPDH
at 58jC) for 30 seconds, and extension at 72jC for 30 sec-
onds over a total of 35 cycles. The reactions were com-
pleted by another incubation step at 72jC for 10 minutes.
PCR products were subjected to electrophoresis in 1.5%
agarose gel and visualized by ethidium bromide.
Statistical Analysis
All experiments were performed three to seven times.
Statistical significance was investigated by Wilcoxon-Mann-
Whitney U test. Differences were considered statistically
significant at P < .05.
Results
HCMVHi Infection
In initial experiments, three different prostate tumor cells
lines were exposed to HCMVHi. The infection rate for DU145
cells was < 1%, as evidenced by immunoperoxidase staining
against the HCMV-specific immediate early protein UL123.
The infection rate for LNCaP was 5%, whereas 30% of PC3
cells stained positively when infected at an MOI of 0.1 or 1
(Figure 1). Early 72-kDa proteins were produced in HCMV-
infected PC3 cells within 24 hours postinfection (p.i.), where-
as 67-kDa late proteins were produced within 72 hours p.i.
Adhesion of PC3Hi to HUVEC
The binding of PC3 to HUVEC monolayers has been
evaluated because adhesive interactions between tumor
cells and the vessel wall reflect the first step of a hema-
togenous invasion cascade. Figure 2 shows PC3 tumor cell
adhesion characteristics evaluated 1 and 3 days p.i. HCMV
infection led to a considerable enhancement of tumor cells,
which adhered to HUVEC. AnMOI of 1, rather than anMOI of
0.1, evoked stronger effects on PC3. The adhesion rate
of tumor cells plated 1 day p.i. increased by 160.0 ± 39.9%
(MOI = 1) vs 86.7 ± 46.2% (MOI = 0.1, mean ± SD, n = 7
experiments), compared to noninfected PC3 control cells.
The adhesion rate of cells plated 3 days p.i. differed by
110.8 ± 30.5% (MOI = 1) vs 75.7 ± 13.2% (MOI = 0.1,
mean ± SD, n = 7 experiments), compared to controls.
Surprisingly, the treatment of PC3 with inactivated virus
particles also induced a significant increase in tumor cell
adhesion, which was most prominent 3 days p.i. (70.3 ±
22.7%, n = 7). Immunoperoxidase staining against the
HCMV-specific IEA1 was negative in PC3 cells treated with
inactivated viruses, excluding any contamination by intact
virus material.
Adhesion of PC3Hi to Collagen, Laminin,
or Fibronectin Matrix
Once tumor cells have attached to the endothelium, direct
interactions with underlying extracellular matrix structures
Figure 1. Immunoperoxidase staining of HCMV (HCMVHi) – infected PC3
prostate tumor cells. PC3 cells were infected at an MOI of 1 and were stained
against the HCMV-specific 72-kDa immediate early protein UL123. The
efficiency of HCMVHi infection was about 30% (original magnification, 100).
Figure 2. HCMV promotes tumor cell adhesion. Mock-infected controls,
HCMVHi-infected cells (MOI = 1 or 0.1), and UV-inactivated PC3 cells were
cultured on HUVEC monolayers for 60 minutes. Nonadherent tumor cells
were washed off in each sample, and the remaining cells were fixed and
counted in five different fields (5  0.25 mm2) using a phase-contrast
microscope. The upper figure presents PC3Hi, infected for 24 hours; the lower
figure is related to PC3Hi, infected for 72 hours. Adhesion capacity is depicted
as tumor cell adhesion per square millimeter (mean ± SD; one of seven
representative experiments).
810 HCMV Modulates PC3 Cell Adhesion Blaheta et al.
Neoplasia . Vol. 8, No. 10, 2006
occur to allow subsequent transendothelial invasion. To
further explore the functional significance of HCMVHi infec-
tion on the invasive behavior of tumor cells, PC3 cells were
therefore added to extracellular matrix proteins, and the
binding rate of infected versus noninfected cells was cal-
culated. The number of adherent control cells differed with
respect to the matrix protein used. Maximum adhesion ca-
pacity was measured on fibronectin-coated and laminin-
coated plates; a lower binding rate was seen when culture
plates were precoated with collagen (Figure 3). Tumor cells
that had been inoculated with HCMVHi showed a binding
activity significantly higher than that of control tumor cells.
Similar to HUVEC adhesion studies, UV-inactivated viruses
also triggered enhanced tumor cell binding. The effect was
independent of the matrix component used and became
evident 1 and 3 days p.i.
HCMVHi Infection Leads to Enhancement of Integrin
Surface Expression
Our data indicated that the adhesion of prostate tumor
cells to the endothelium or matrix is altered by HCMVHi. We
next explored whether virus infection leads to adhesion
receptor alteration of the b1-integrin family, whereby all sub-
sequent experiments were related to an MOI of 1. Integrin b1
subtypes are predominantly involved in cell adhesion to the
extracellular matrix. a1, a2, and a3 b1 integrins can bind
various matrix types, whereas a4 and a5 primarily react with
fibronectin and a6 primarily reacts with laminin. To distinguish
PC3Hi from PC3 in the same cell population, cell cultures
were double-stained, and IEA+ versus IEA tumor cells were
analyzed separately. Analysis of HCMVHi-infected tumor cell
cultures demonstrated 28.4 ± 6.9% IEA+ cells (mean from six
experiments), the integrins of which were significantly ele-
vated compared to the subset of noninfected IEA cells
(3 days p.i.; Figure 4). Most prominently, a4 integrin subtype
was not expressed on IEA cells, but strong fluorescence
signals were detected on IEA+ cells. This might speak for
the de novo synthesis of a4 proteins; indeed, RT-PCR dem-
onstrated only moderate a4 mRNA activity in noninfected
PC3 cells, whereas strong a4 mRNA activity in PC3
Hi cells
was noted. Furthermore, a4 protein content increased in PC3
cells after HCMVHi infection (Figure 5). mRNA analysis of
integrin b1A did not reveal significant differences between
HCMV-infected and control cells, which underlines flow cy-
tometry data.
In strong contrast to HCMVHi-induced alterations of the
b1-integrin profile, UV-inactivated viruses exerted no quanti-
tative changes on b1 integrins, compared to controls (data
not shown).
FAK (total and phosphorylated) and ILK were analyzed in
ongoing experiments as surrogates for integrin-mediated
signalling. In good accordance with integrin data, HCMVHi
cells were characterized by enhanced ILK and FAKphospho
levels (24 hours p.i.), whereas this effect was not seen in
UV-inactivated or mock-infected cells (Figure 6).
The relevance of b1 integrins for adhesion events was
explored by blocking studies using b1 monoclonal antibodies
(clone 6S6). In this context, the adhesion of PC3 cells to
HUVEC, fibronectin, laminin, or collagen was drastically
inhibited by b1-blocking antibodies (but not by corresponding
Figure 3. The adhesion of prostate tumor cells to extracellular matrix proteins depends on HCMVHi. PC3 cells were added to immobilized fibronectin, laminin, or
collagen for 60 minutes. Mock-infected controls, as well as HCMVHi-infected (MOI = 1 or 0.1) or UV-inactivated PC3 cells, were used. Nonadherent tumor cells
were washed off in each sample, and the remaining cells were fixed and counted in five different fields (5  0.25 mm2) using a phase-contrast microscope. Mean
values were calculated from five counts. Specific adhesion capacity (background adhesion on the plastic surface was subtracted from adhesion to matrix proteins)
is depicted as counted cells per 0.25 mm2. One of six representative experiments is shown.
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IgG isotype controls), which speaks for a link between integrin
upregulation and the enhancement of tumor cell–endothelium
or tumor cell–matrix interactions, respectively (Figure 7).
HCMVHi Modulates c-myc Expression
To further evaluate the oncomodulatory potential of
HCMVHi, c-myc protein was analyzed subsequently. The flow
cytometry of IEA+ versus IEA cells in infected tumor cell
cultures revealed only little intracellular c-myc protein in IEA
cell populations, but significantly enhanced protein levels in
IEA+ cell populations. This was already detectable 1 day p.i.,
but became most evident 3 days p.i. (Figure 8). Flow cytom-
etry data were confirmed by Western blot analysis, demon-
strating increased c-myc in PC3Hi cells, compared to PC3
controls (Figure 8). The application of UV-inactivated viruses
did not lead to any changes in c-myc (data not shown).
IEA1 and IEA2 Proteins Are Not Involved in the Regulation
of Adhesion Processes
To investigate the role of immediate early and late proteins
in regulating tumor cell adhesion, PC3 cells were transfected
with cDNA encoding HCMV IEA1 (pHM135), HCMV IEA2
(pHM134), or both (pHM127). Interestingly, none of the trans-
fected cell populations showed different adhesion character-
Figure 4. 1-Integrin surface expression on HCMV
Hi-infected versus noninfected PC3 cells. To determine whether integrin modulation was restricted to HCMVHi-
infected PC3 cells, cell cultures were double-stained using, on the first step, a monoclonal antibody directed against the HCMV-specific 72-kDa IEA, labeled with
FITC. On the second step, PC3 cells were marked with the PE-conjugated monoclonal antibodies anti-CD49b (a21), anti-CD49c (a31), or anti-CD49d (a41). IEA

(PC3Hi) and IEA+ cells (PC3Hi+) were gated to obtain two distinct cell populations: population I (IEA+) as HCMV-infected cells, and population II (IEA) as
noninfected tumor cells. The integrin expression of both PC3 subtypes was then detected by FACScan analysis [FL-2H(log) channel histogram analysis; 1  104
cells/scan]. To evaluate background staining, mouse IgG1–PE was used as isotype control.
Figure 5. Top: Western blot analysis of a41 integrin from the proteins of
HCMVHi versus mock-infected PC3 cells. Cell lysates were subjected to SDS-
PAGE and blotted on the membrane incubated with anti –a41 monoclonal
antibody. -Actin served as internal control. The figure shows one of three
representative experiments. Bottom: RT-PCR analysis of a41 integrin coding
mRNA. HCMVHi versus mock-infected PC3 cells were used. RNA was
extracted, reverse-transcribed, and submitted to semiquantitative RT-PCR
using gene-specific primers, as indicated in the Materials and Methods
section. The figure shows one of three representative experiments.
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isticswhen compared to controls. In line with this observation,
the expression of integrin b1 subtypes did not change in
transfected versus nontransfected PC3 cells (data not
shown). However, an examination of oncogenic proteins
revealed distinct differences in c-myc content among PC3
variants (Figure 9). Fluorometry in double-stained PC3pHM127
cells presented evidence of elevated c-myc levels, compared
to nontransfected PC3 levels. Western blot assays demon-
strate an enhanced c-myc content in all transfectants. The
changes were most prominent in PC3pHM127 and PC3pHM135,
indicating that c-myc was mainly upregulated by IEA1.
Discussion
Based on a cell culture model, we demonstrate for the first
time that infection of PC3 cells with HCMV significantly alters
their invasive properties, as evidenced by enhanced tumor
cell adhesion to the endothelium and extracellular matrix
proteins. This discovery is fundamental to understanding
HCMV’s role in prostate cancer progression and supports
the concept of cytomegalovirus-mediated oncomodulation
[12]. Previously, we reported an enhanced invasiveness of
Figure 6. HCMVHi modulates ILK, FAK, and FAKphospho. Mock-infected controls, HCMVHi-infected cells (MOI = 1), and UV-inactivated PC3 were examined by
appropriate monoclonal antibodies, as indicated in the Materials and Methods section. -Actin served as internal control. One of three representative experiments
is shown. The x-axis indicates the time after HCMVHi infection.
Figure 7. Adhesion of PC3 to HUVEC or extracellular matrix proteins is
integrin-dependent. PC3 cells were preincubated with 1 function–blocking
antibodies (clone 6S6) and then added to HUVEC monolayers or immobilized
collagen, laminin, or fibronectin. Adherent cells were counted after 60 minutes.
The adhesion of cells not treated with monoclonal antibodies was set at 100%.
Adhesion blockade diminished the adhesion to HUVEC and extracellular
matrix proteins. One of three representative experiments is shown.
Figure 8. Two-channel fluorescence and Western blot analysis of c-myc.
Top: HCMVHi-infected PC3 cell cultures were double-stained using, on the
first step, a monoclonal antibody directed against the HCMV-specific 72-kDa
IEA, labeled with FITC. On the second step, PC3 cells were marked with the
PE-conjugated anti –c-myc monoclonal antibody. IEA (PC3Hi) and IEA+
cells (PC3Hi+) were gated to obtain two distinct cell populations: population I
(IEA+) as HCMV-infected cells, and population II (IEA) as noninfected tumor
cells. The c-myc expression of both PC3 subtypes was then detected by
FACScan analysis [FL-2H(log) channel histogram analysis; 1  104 cells/
scan]. To evaluate background staining, mouse IgG1–PE was used as
isotype control. Bottom: Western blot analysis of c-myc from the proteins of
HCMVHi (MOI = 1) versus mock-infected PC3 cells. Cell lysates were
subjected to SDS-PAGE and blotted on the membrane incubated with c-myc
monoclonal antibody. -Actin served as internal control. The figure shows
one of three representative experiments.
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HCMV-infected neuroblastoma cell lines when compared to
the invasive capacity of noninfected variants [8]. Harkins et al.
[13] described the specific localization of HCMV nucleic acids
and proteins to neoplastic cells in human colorectal polyps
and adenocarcinomas. However, reinvestigation of a larger
tumor collective did not confirm the association between
carcinogenesis and the progression of colorectal cancer
and HCMV infection [14]. It is therefore difficult to assess
whether our observation represents a unique phenomenon or
if tumor-promoting properties of HCMVare a general feature
that might occur in most, if not all, tumor types.
HCMV infection led to a significant upregulation of b1-
integrin receptors on PC3 cells in our experiments. Further-
more, b1-blocking antibodies inhibited tumor cell adhesion to
the endothelium or matrix proteins. We therefore conclude
that (1) integrins of the b1 family coordinate the interaction
between prostate tumor cells and the endothelium/extracel-
lular matrix, and (2) HCMV’s effects on PC3 cell adhesion are
caused by the elevation of integrin b1 receptors.
Several reports corroborate the role of integrin proteins as
key mediators of adhesion, migration, and invasion. Scott
et al. [15] showed that blocking antibodies to the b1-integrin
subunit inhibited the adhesion of PC3 cells to bone marrow
endothelial cells by 64%. Notably, osteoblast-mediated PC3
tumor cell motility and invasiveness were accompanied by
increased a2b1 and a3b1 integrin expressions [16]. These
observations are in line with our postulation of HCMV-
triggered integrin enhancement. Nevertheless, we should
be aware that changes in b1-integrin surface localization
and activity status might also determine the metastatic be-
havior of prostate tumor cells. Hypothetically, HCMV could
also act on the affinity of integrin receptors.
Indeed, elevated levels of ILK, as well as the promotion of
FAK phosphorylation, were also observed in our cell culture
model. Both proteins serve as important downstream com-
ponents of integrin-mediated signalling and are involved in
prostate cancer progression and invasiveness [17,18].
In this context, ectopic expression of active ILK in mam-
mary epithelial cells induced a dramatic reorganization of the
actin cytoskeleton and promoted rapid cell spreading [19].
Cherubini et al. [20] demonstrated that tyrosine phosphory-
lation of FAK may represent the necessary step to switch on
the motility and invasiveness program in b1-integrin –
expressing tumor cells. It therefore seems likely that integrin
overexpression, combined with the modulation of integrin-
dependent signalling, is responsible for the acquisition of
a more invasive—and thus more malignant—phenotype of
PC3Hi tumor cells.
Novel data also support a critical role for a2b1 and a6b1
integrins as HCMV entry receptors [21]. Monoclonal anti-
bodies to integrin subunits blocked both direct virus entry
and HCMV gene expression. Cells lacking b1 integrins were
deficient in both entry and cell–cell spread of the virus, and
the restoration of b1-integrin expression in the same cell line
restored both phenotypes. It is assumed that integrins serve
as HCMV coreceptors that interact with the epidermal growth
factor receptor (EGFR) to induce coordinated signalling. The
coordination between integrins and EGFR seems to be
crucial for successful viral infection [22]. Along with the role
of integrins as adhesion regulators, HCMV probably estab-
lishes a symbiotic relationship between viruses and tumor
cells. A high integrin expression level guarantees a high
infection rate and simultaneously allows more tumor cells to
become invasive (which may also serve as a mechanism of
survival and escape from the host immune system). From a
clinical viewpoint, the positive feedback mechanism between
HCMV infection and integrin upregulation might dramatically
accelerate prostate cancer dissemination and progression.
Nevertheless, we did not evaluate further adhesion recep-
tors in our study. Therefore, receptors different from b1
integrins may also be altered during HCMV infection and
may be involved in virus-induced tumor cell adhesion events.
This includes cadherins, selectins, CD44 receptors, or re-
ceptors of the CAM family.
The HCMV-induced modulation of neuroblastoma cell in-
vasion was accompanied by distinct alterations of c-myc pro-
tein expression [8]. We consequently investigated whether
this mechanism might also apply to the pathogenesis of
prostate cancer. Indeed, the level of c-myc protein, an impor-
tant oncogene in prostate cancer, was significantly increased
in PC3Hi cells, compared to that in controls. A series of
investigators has reported that c-myc amplification is present
in up to 50% of high-grade prostatic intraepithelial neo-
plasia and 70% of primary prostate cancer, and that c-myc
Figure 9. c-myc expression depends on the HCMV-specific immediate early
protein IEA1. cDNA encoding HCMV IEA1 (UL123) was cloned into the
pBS+/ vector and inserted in the expression vector pHM135. cDNA encoding
HCMV IEA2 (UL122) was cloned into the pBS+/ vector and inserted in the
expression vector pHM134. cDNA encoding HCMV IEA1 and IEA2 was
cloned into the pUC18 vector and inserted in the expression vector pHM127.
Control cells were transfected with vectors alone. The upper diagram
presents a two-channel analysis of c-myc expression of pHM+ versus pHM
PC3 cell populations. Detailed information about cell staining is given in the
Materials and Methods section. The lower diagram presents Western blot
analysis of c-myc protein expression level. -Actin served as internal control.
The figure shows one of three representative experiments.
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amplification, with increasing Gleason score, increases with
transition from prostatic intraepithelial neoplasia to localized
prostate cancer to metastases [23].
Nevertheless, c-myc data are difficult to interpret, as the
role of this protein in human cancer is complex and as no clear
conclusion can be drawn about its definitive function in
regulating cell adhesion. Our observation that UV-inactivated
viruses did not lead to any changes in c-myc, although cell
adhesion was enhanced significantly, does exclude a direct
link between c-myc expression and tumor invasion. Several
reports point to c-myc as a stimulator of cell cycle. Transgenic
mouse models overexpressing c-myc in the prostate ex-
hibited a dose-related progression toward malignancy. The
resulting tumors resembled a poorly differentiated advanced
carcinoma with accelerated growth rate, evidenced by Ki67+
cells [24]. It is speculated that amplification of c-myc may
have two explanations. At early stages, c-myc can confer a
proliferative advantage by immortalizing prostate cells and
by allowing them to grow under limited growth factor con-
ditions. At later stages, c-myc may contribute to androgen-
independent growth of prostate cancers. Based on this,
HCMV-induced c-myc elevation might be sufficient to mod-
ulate carcinogenic events per se, but might not be directly
coupled to the enhancement of adhesion processes.
According to the observation of Wang et al. [22], the
attachment of UV-irradiated HCMV particles to PC3 cells
evoked a distinct response, characterized by enhanced
tumor cell binding to HUVEC and extracellular matrix pro-
teins. This phenomenon clearly indicates that a physical
association between the virus and host molecules (without
virion delivery) has been established, reflecting an impor-
tant event during HCMV-evoked oncomodulation and tumor
dissemination. Even inactivated HCMV isolates might be
sufficient to induce enhanced tumor cell invasiveness. Con-
sequently, a therapeutic strategy that prevents both HCMV
replication and docking at the tumor cell membrane is re-
quired. The underlying mode of action is not clear. Irradiated
virus particles did not influence integrin expression level or
ILK/FAK activity. Smith et al. [25] reported that a primary
HCMV infection of human peripheral blood monocytes pro-
moted transendothelial migration, increased cell motility, and
upregulated adhesion molecule expression. UV-inactivated
HCMV also evoked enhanced transendothelial migration,
but not enhanced integrin expression, in this experiment.
We therefore speculate that HCMV promotes tumor cell
transmigration independently of viral gene expression.
In line with this speculation, transfection of PC3 cells with
IEA1 or IEA2 cDNAdid not induce any alterations of adhesion
behavior and integrin expression, although c-myc was in-
creased in these cells compared to controls. Shen et al. [26]
showed recently that IEA1 and IEA2 evoke mutations in the
p53 gene in rat kidney cells. Furthermore, c-myc and p53
were significantly elevated in endothelial cells or fibroblasts
transfected with IEA1 and IEA2 plasmids [27,28], suggesting
the oncogenic potential of IE proteins. Given the oncogenic
activity of IEA1 and IEA2, it is not clear why they did not act
on the tumor cell adhesion process in our culture system.
One plausible explanation for this observation is that IEA1
and IEA2 only partially contribute to the invasive phenotype.
Rather, a full infection scenario must proceed to alter the
malignant properties of prostate cancer cells. Notably, HCMV
attachment and infection at entry seem to play a crucial role
in switching tumor cells from a low adhesive state to a high
adhesive state. Wang et al. [22] pointed out that a cross-talk
between EGFR and integrin receptors is necessary to allow
successful HCMV infection and adequate downstream sig-
nalling. Indeed, blockade of integrin receptors inhibited
HCMV virion content delivery and infectivity, while not in-
hibiting cell binding [22]. HCMV might, therefore, engage
multiple receptors to form a multicomponent receptor com-
plex and a functional signalling platform.
A second explanation is that IEA1 and IEA2 may promote
malignant transformation by dysregulating various normal
cellular physiological processes that specifically control cell
cycle. IE proteins can interact with key regulatory proteins in
the cell (e.g., members of the retinoblastoma family of pro-
teins), resulting in the induction of DNA synthesis. The IE86
protein has also been shown to interact with the tumor-
suppressor protein p53 (although we are aware that PC3
cells represent p53/mutants). In addition, the levels of the
oncogenes c-myc, c-fos, and c-jun, as well as of cyclin E and
cyclin-dependent kinases, are also rapidly upregulated fol-
lowing HCMV infection [29].
The elevated levels of c-myc found in IEA1-transfected or
IEA2-transfected PC3 cell populations suggest that HCMV
proteins might activate promoters involved in the regulation
of cell proliferation, but might not directly modulate integrin-
dependent tumor cell migration.
Based on our in vitro model, we postulate a direct asso-
ciation betweenHCMV infection and prostate tumor adhesion
characteristics. HCMV shares the capacity of upregulating
intracellular c-myc protein content in PC3 cells and evokes an
elevated surface expression of b1-integrin adhesion recep-
tors, alongwith activation of downstreamsignalling. The latter
effects are attributed, at least in part, to an enhanced invasive
capacity of tumor cells. Further studies should explore the
effects of antiviral therapy on prostate tumor growth and
dissemination in vivo.
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